KEAP1 and lung carcinoma: In lung cancer cells, CDK20 can compete with Nrf2 to bind to Keap1, enhance the transcriptional activity of Nrf2 and reduce the level of ROS, thereby promoting the continuous proliferation of cancer cells (131).